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ABSTRACT 32 
Duchenne Muscular Dystrophy (DMD) is a progressive neuromuscular disease, caused by an 33 
absence of dystrophin, inevitably leading to death. Although muscle lesions are well 34 
characterised, blood vessel alterations that would have major impact on muscle regeneration, 35 
remain poorly understood. Our aim was to elucidate alterations of the vascular network 36 
organisation, taking advantage of Flk1GFP/+ crossed with mdx mice (model for human DMD 37 
where all blood vessels express GFP) and functional repercussions using in vivo nuclear 38 
magnetic resonance (NMR), combining arterial spin labeling imaging of perfusion, and 31P-39 
spectroscopy of phosphocreatine kinetics. For the first time, our study focused on old (12 40 
month-old) mdx mice, displaying marked chronic muscle lesions, very similar to the lesions 41 
observed in human DMD, in comparison to young-adult (3 month-old) mdx mice displaying 42 
only mild muscle lesions with no fibrosis. Using an original approach combining specific 43 
animal model, state of the art histology/morphometry techniques, and functional NMR, we 44 
demonstrated (i) that the microvascular system is almost normal in young-adult in contrast to 45 
old mdx mice, displaying marked microvessel alterations, and (ii) functional repercussions on 46 
muscle perfusion and bioenergetics after a hypoxic stress, that vary depending on stage of 47 
pathology. This original approach clarifies disease evolution and paves the way for setting up 48 
new diagnostic markers or therapeutic strategies. 49 
  50 
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INTRODUCTION 51 
Duchenne muscular dystrophy (DMD) is the most frequent genetic neuromuscular disorder 52 
affecting 1:3500 school-age boys worldwide. This X-linked muscle disease is characterised 53 
by progressive skeletal muscle weakness and cardiomyopathy, leading to premature death 54 
generally because of respiratory and/or cardiac failure. The cause of DMD is the absence of 55 
dystrophin, a key component of the dystrophin-associated protein complex involved in the 56 
linkage between myofiber cytoskeleton and extracellular matrix. When linkage is disrupted, 57 
muscle fibers develop normally but are more susceptible to damage due to mechanical 58 
stretch. Despite presence of satellite cells (muscle stem cells) and successive regeneration 59 
attempts, myofibers undergo necrosis and are eventually replaced by connective and adipose 60 
tissue 1. 61 
Muscle lesions in DMD have been widely investigated, with studies focusing principally on 62 
myofibers and/or satellite cells (SC). Although (i) skeletal muscle is one of the most 63 
vascularised tissues, (ii) endothelial cells are essential in muscle regeneration process, and 64 
(iii) dystrophin is expressed in endothelial/smooth muscle cells, disease impact on blood 65 
vessels and effect of blood vessel alteration in disease expression remain poorly understood. 66 
In recent years, interest in DMD vascular network has increased with primary focus on 67 
vasculature-related therapeutic strategies 2 such as methods to increase vasculature by 68 
modulating VEGF/VEGFR pathways 3. These strategies were initially based on: (i) 69 
observation of “grouped necrosis” in muscles of DMD patients, i.e. simultaneous necrosis of 70 
contiguous myofibers, suggesting local failure in capillary blood supply and muscle ischemic 71 
necrosis 4, and (ii) membrane-associated nitric oxide synthase (NOS) deficiency in 72 
dystrophin-deficient muscle 5. The hypothesis of an ischemic process has been strongly 73 
discussed, as other studies could not detect any vascular bed abnormality in DMD either 74 
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morphologically using electron microscopy 6 or physiologically by studying muscle blood 75 
flow 7-9. More recent studies carried out in DMD patients confronted blood vessel alteration 76 
with tissue fibrosis. They suggested that endomysial fibrosis plays an essential role, causing 77 
an increase in capillary-to-myofiber distances, which impairs both muscle fiber mechanical 78 
function and gas exchanges 10. Moreover, increased distances between capillaries and 79 
myofibers could potentially impede their reciprocal stimulation by soluble factors secreted 80 
during muscle repair 11. 81 
Rare studies addressed the relevance of muscle vascular network in dystrophinopathy 82 
pathophysiology in animal models, focusing on muscle vascular density and characterisation 83 
of a possible hypoxic condition in dystrophic muscle. Part of these studies pointed to a 84 
decreased vascular density and an impaired angiogenesis in 6 week- to 6 month-old mdx 85 
mice 12-14 the dystrophin-deficient murine model of human DMD. However, contradictory 86 
results were also published in mdx mice, showing a higher hindlimb perfusion one week after 87 
femoral artery dissection and significant increase in arteriole length density in 2 month-old 88 
animals 15. These discrepancies could be related in part to the effect of aging in disease 89 
progression; age appears to be an important parameter to consider when studying vascular 90 
changes 3. Thus, involvement of blood vessels in the pathogenesis of dystrophy is still not 91 
completely understood.  92 
In the present study, we investigated both structural organisation and in vivo function of 93 
vascular system in young-adult (3 month-old) mdx mice, displaying only moderate subacute 94 
muscle lesions with no fibrosis, and old (12 month-old) mdx mice, displaying marked muscle 95 
lesions with persistent inflammation and fibrosis 16, more relevant for the study of DMD 96 
pathophysiology in human. We used complementary morphological approaches based on 97 
genetically-modified mice that allowed for the first time to reconstruct the 3-dimensional 98 
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microvascular network in mdx mouse. These were confronted to innovative histological 99 
techniques and dynamic and non-invasive multiparametric and functional nuclear magnetic 100 
resonance (NMR). 101 
 102 
MATERIAL AND METHODS 103 
Mice 104 
C57Bl/6J control mice were obtained from Charles River Laboratory (l’Arbresle, France), 105 
mdx-4Cv with C57Bl/6 background mice, model for human DMD, were kindly provided by 106 
Pr. Gherardi (Hôpital Henri Mondor, France), Flk-1GFP/+ mice, in which green fluorescent 107 
protein (GFP) is targeted in vascular endothelial growth factor (VEGF) receptor-2 gene locus, 108 
exhibiting a bright GFP signal in all endothelial cells, were kindly provided by A. Medvinsky 109 
(Institute for Stem Cell Research, University of Edinburgh, UK), and Flk-1GFP/+::mdx-4Cv 110 
mice were obtained by crossing Flk-1GFP/+ with mdx-4Cv mice. Only male animals were used 111 
i.e. young-adults (3 month-old) or old (12 month-old).  112 
Animals were housed in animal facilities of the Institut Pasteur licensed by the French 113 
Ministry of Agriculture and complying with European Union regulations. Protocols were 114 
approved by the Institut Pasteur Animal Experimentation Ethics Committee (01332.01). 115 
 116 
Microvascular network organisation in three dimensions 117 
Young-adult and old Flk-1GFP/+ and Flk-1GFP/+::mdx-4Cv mice were anesthetised with 118 
isoflurane inhalation (Forene, Abbott, Rungis, France) and killed by cervical dislocation. 119 
Gastrocnemius muscles were removed and imaging of vascular network was carried out in 120 
two conditions: thick cryo-sections or whole muscle. Gastrocnemius muscle was snap frozen 121 
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in liquid nitrogen-cooled isopentane before cryosectionning (100 !m-thick sections). 122 
Confocal acquisitions were performed using a spinning disk microscope (Leica, Wetzlar, 123 
Germany), laser femto-second was used: Chameleon Ultra, 20"/0.7 and 40x/0.75 objectives 124 
and a CoolSnap HQ2 camera. Optical slices were taken every 0.5 or 0.3 µm interval along 125 
the z-axis (80 µm). 126 
For whole muscle conditions, images of Gastrocnemius blood vessels were obtained from the 127 
entire muscle using multi-photon scanner resonant confocal Leica TCS-SP5 with 20x/0.95 128 
objective. Optical slices were taken every 0.5 µm along the z-axis. 129 
 130 
Histological/Immunohistochemical analysis 131 
Gastrocnemius muscles were collected from mice after NMR experiments, snap frozen in 132 
liquid nitrogen-cooled isopentane and kept at –80°C. Six different levels of 7 µm-thick 133 
sections were cut and stained with hematoxylin-eosin (HE) to describe histopathological 134 
modifications of muscle tissue, and Sirius red for visualisation of collagen. For 135 
immunohistochemistry analyses, muscle cryosections were incubated with antibodies 136 
directed against endothelial cells (anti-CD31; Pharmingen), satellite cells (anti-Pax7; DHSB, 137 
Iowa city, IA, USA), pericytes (anti-NG2; Millipore), smooth muscle cells (!SMA; Sigma) 138 
and basal lamina (anti-laminin; Sigma). Primary antibodies were incubated overnight at 4°C 139 
and revealed by cy3- or TRITC-labeled secondary antibodies (Jackson ImmunoResearch 140 
Laboratories). 141 
 142 
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Morphometric analysis 143 
Two-dimension analysis was performed to evaluate distribution of muscle fiber diameter, 144 
percentage of centro- or peri-nucleated fibers, microvessel count and distribution around each 145 
myofiber using ImageJ (NIH, Bethesda, MD, USA) and NIS-Element (Nikon) softwares. At 146 
least 200 fibers were considered for each muscle. 147 
Three-dimensional analysis was performed to evaluate organisation of vascular network. For 148 
each muscle, 10 z-stack image reconstructions were achieved on 80 to 150 µm-thick frozen 149 
sections. Analysis was carried out using IMARIS (ImarisBitplane, Zurich, Switzerland) 150 
software (quantification of vessel density, tortuosity, volume, anastomose count, diameter 151 
and distance between microvessels). 152 
 153 
Quantitative RT-PCR 154 
We used real-time PCR to determine the level of angiogenesis-related mRNA expression in 155 
young-adult and old mdx mice. Total Gastrocnemius muscle RNA was extracted using 156 
RNeasy Mini Kit (Qiagen). One !g of total RNA was reverse transcribed into first-strand 157 
cDNA using Superscript II Reverse Transcriptase (Life technologies). Quantitative PCR was 158 
carried out on StepOne Plus RealTime PCR system (Applied Biosystems, Carlsbad, CA, 159 
USA). Reaction mixtures had a final volume of 20 !l, consisting of 1 !l of cDNA, 10 !l of 160 
Sybr Green Master (Roche) and 10 !M of primers, listed in Table 1. After initial 161 
denaturation, amplification was performed at 95°C (10 s), 60°C (5 s), 72°C (10 s) for 45 162 
cycles. Calculation of relative expression was determined by the StepOnePlus software 163 
(Applied Biosystems) and fold change was normalized to 18S rRNA housekeeping gene. 164 
 165 
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Nuclear Magnetic Resonance analysis 166 
NMR experiments were performed on: 3 month-old mdx-4Cv (n=6) and control C57Bl/6J 167 
(n=9) and on 12 month-old mdx-4Cv (n=5) and control C57Bl/6J (n=7). 168 
Hyperaemic response paradigm: To highlight differences between normal and altered 169 
muscles we classically applied a stress to increase the global need for perfusion. Ischemia-170 
reperfusion stress was applied to the mouse left hindlimb which provokes maximal 171 
vasodilatation and limited resistance of arteries/arterioles 17 just after tourniquet release. 172 
In practice, anaesthesia was induced with 4% isoflurane delivered in 1.5 L/min air and 173 
maintained with 1.75% isoflurane. During experiments, a water heating pad ensured a 174 
constant temperature of 37°C and breathing was monitored. After a 24 min NMR acquisition 175 
at rest (baseline), ischemia of the leg was induced by occlusion of femoral artery by two 176 
surgical threads placed around the thigh and pulled tight by application of a weight 17. After 177 
30 min of ischemia, the weight was instantly removed, inducing a hyperaemic response 178 
which was monitored over the next 30 min. During whole protocol, dynamic acquisitions of 179 
NMR scans of interleaved perfusion imaging and 31P-spectroscopy (31P-NMRS) were 180 
collected. 181 
Multiparametric functional NMR (mpf-NMR) acquisitions. In vivo NMR experiments were 182 
conducted in a 4 Tesla Biospec system equipped with a 20 cm diameter 200 mT.m-1 gradient 183 
insert (BrukerBioSpin MRI GmbH, Ettlingen, Germany). Mice were placed supine in a 6 cm 184 
diameter, 12 cm length volume transmitter 1H coil for whole-body signal excitation. An 185 
actively decoupled 2 cm diameter surface 1H coil, positioned below the left calf, was used for 186 
image signal reception. Muscle metabolites were probed by a 10 mm 31P saddle-shaped coil 187 
placed around the left leg. 188 
 10 
As described in detail elsewhere 17, 18, Arterial Spin Labeling (ASL)-NMR imaging and 31P-189 
NMRS acquisitions were interleaved using the dedicated Bruker MultiScanControl software 190 
(BrukerBioSpin GmbH) in order to follow simultaneously and non-invasively: (i) muscle 191 
perfusion signal by SATuration-Inversion Recovery (SATIR) (time resolution: 10 sec), and 192 
(ii) mitochondrial activity by dynamic 31P-NMRS (time resolution: 2.5 sec). In brief, ASL 193 
imaging is based on non-invasive alternate magnetic tagging of blood water spins to provide 194 
endogenous markers of muscle perfusion, measured in regions of interest (ROI) drawn in 195 
posterior compartment of the leg. Muscle bioenergetics and pH were assessed from ratios of 196 
energetic phosphates measurable by 31P-NMRS at rest, in vivo mitochondrial oxidative 197 
capacity was directly assessed from the rate of creatine rephosphorylation at the end of 198 
ischemia, and intramuscular pH was calculated from chemical shift between phosphocreatine 199 
(PCr) and inorganic phosphate (Pi). A minimum of 50% PCr depletion at the end of ischemia 200 
was necessary to reliably measure dynamics for PCr recovery, and examinations which did 201 
not reach this threshold were rejected. 202 
NMR perfusion analysis. Images were acquired after positive or negative labeling alternately. 203 
To avoid large vessels, ROI were drawn in the posterior compartment of the leg. Muscle 204 
perfusion f was calculated from the normalized difference between consecutive images 205 
according to the equation 19: 206 
! ! ! ! !!" !!"
!! !!!
!! !!! ! !! !"# !!!!" ! !  
where r1 is the longitudinal relaxation rate for muscle (measured by saturation-recovery 207 
acquisition for each mouse at the end of 30 minutes hyperaemic period), M+ and M- are the 208 
signals of positive and negative labelled perfusion images and " is the blood-tissue partition 209 
coefficient (" =0.9). 210 
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31P-NMR Spectroscopy analysis. Successive 31P Free Induction Decays were acquired 211 
throughout rest, ischemia and hyperaemia. 31P-spectroscopy gives access to principal 212 
metabolites implicated in energetic metabolism such as phosphocreatine (PCr), the three !, #, 213 
$ ATP and inorganic phosphate (Pi). Signal intensity of these resonances is directly 214 
proportional to their concentrations, which allows the quantitative following of these 215 
metabolite variations. 216 
At ischemia and recovery, PCr recovery was fitted by a mono-exponential function with a 217 
least mean squares algorithm and pH was calculated from the chemical shift %Pi between PCr 218 
and Pi according to the formula 20:  219 
!" ! !!!"! !"# !!!"! !!" !!" ! !!!"  
Statistics 220 
Perfusion data were analysed by repeated measurements ANOVA. Analyses were performed 221 
with NCSS-2007 software (Kaysville, UT, USA). Group comparisons for perfusion 222 
parameters and phosphorus spectroscopy analysis were performed using Mann-Whitney test. 223 
Statistical analysis of histological data was performed with GraphPad-Prism software (La 224 
Jolla, CA, USA). Fiber diameter repartition was evaluated by a chi-square test followed by a 225 
multi-t-test corrected for multiple comparisons using Holm-Sidak method. Same multi-t-test 226 
was used to evaluate capillary count/fiber repartition. 227 
Statistical significance was taken at p<0.05 and p-values indicated on figures are *p<0.05, 228 
**p <0.01, and ***p<0.001. Numerical NMR and histological data are reported as mean±SD. 229 
 230 
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RESULTS 231 
Microvessels were defined as the small blood vessels located at the periphery of myofibers, 232 
in the endomysium, displaying a diameter of less than 20 µm and a wall sometimes 233 
containing one layer of !SMA-expressing cells, thus including capillaries, terminal arterioles 234 
and terminal venules 21. 235 
Young-adult Flk1GFP/+::mdx mice display a normal microvascular network organisation 236 
but a mild decrease in terminal arteriole density. 237 
Polyphasic subacute lesions, characterised by small inflammatory infiltrates and centrally 238 
nucleated fibers, were observed in Gastrocnemius muscle (Figure 1A-B). Surprisingly, these 239 
lesions had no impact on blood microvascular network organisation. In both Flk1GFP/+ and 240 
Flk1GFP/+::mdx mice, vascular network was indeed well organised with straight microvessels 241 
located along myofibers, parallel to each other with few anastomoses oriented 242 
perpendicularly to myofibers (Figure 1C-F). Microvessel diameter, measured using diameter 243 
of endothelial cell fluorescence, was similar in both groups (13-14 µm), as well as 244 
anastomose count (1,200-1,650 anastomoses/mm3) (Figure 1G-H).  245 
Immunofluorescence analyses did not detect any significant difference between young-adult 246 
wild-type and mdx mice (Figure 2). Both muscles displayed the same myofiber cross-section 247 
diameter, fiber size distribution, and microvessel density, quantified by microvessel count per 248 
fiber. No macrovascular modification was detected either (data not shown). To characterise 249 
further the microvascular network and identify terminal arterioles, we carried out an 250 
immunohistochemistry against !SMA, highlighting perivascular smooth muscle cells. We 251 
quantified a 26% loss of #SMA expression in mdx mice, suggesting a decrease in terminal 252 
arteriole density (Figure 3I, J, L). Collectively, these results highlighted a normal 253 
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microvascular network organisation in muscles of both groups, but a mild decrease in 254 
terminal arteriole density, in mdx mice. 255 
Capillary-to-fiber perimeter exchange index (CFPE) has been used to calculate the contact 256 
surface area between capillaries and myofibers. It provides an indirect quantitative criterion 257 
to evaluate movement of oxygen from capillaries to muscle fibers 22. CFPE index was not 258 
affected in young-adult mdx mice (Figure 2F). 259 
As almost no alteration of the microvascular network was detected at the morphological 260 
level, we investigated the expression of angiogenesis-related mRNA (VEGF and its receptors 261 
Flk1 and Flt1, CD31, Ang1, Ang2 and Tie1, Tie2 receptors and nNOS) (Figure 4A). We did 262 
not observe any significant modification of these mRNA expression in young-adult mdx 263 
mice, suggesting no stimulation of the angiogenesis process. In contrast, nNOS expression 264 
was significantly decreased in young-adult mdx mice.  265 
 266 
Similar pericyte density but increase in satellite cell count in young-adult mdx mice. 267 
Using immunohistochemistry analysis, we focused on important partners of endothelial cells: 268 
pericytes and satellite cells. Concerning pericytes (NG2+ cells located at the periphery of 269 
blood vessels in muscle sections 23), no difference in density per mm2 was detected between 270 
wt (151.6±14.3 pericytes/mm2, n=5) and mdx (154.3±21.2 pericytes/mm2, n=5) mice (Figure 271 
3I-K). Satellite cells (SC; Pax7+ cells) are in a close relationship with endothelial cells and 272 
coupling between myogenesis and angiogenesis takes place concomitantly during muscle 273 
regeneration 24. In young-adult mdx mice, we demonstrated using immunofluorescence an 274 
increase in SC count per mm2 (wt: 14.5±0.3 SC/mm2, n=4; mdx: 29.7±3.5 SC/mm2, n=6; 275 
p<0.01) and per fibre (wt: 0.04±0.01 SC/fibre, n=4; mdx: 0.07±0.01 SC/fibre, n=5; p<0.05), 276 
in comparison to wt (Figure 3A-D). 277 
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 278 
Muscle blood perfusion is modified in young-adult mdx mice. 279 
In accordance with our previous observations, profiles of reactive hyperaemia were 280 
significantly different in mdx (n=6) and wt (n=9) mice (Figure 5A, p<10-6 with ANOVA). 281 
The release of ischemia provoked an instantaneous increase of perfusion which was lower in 282 
wt mice (mdx: 78.7±27.1 ml/min/100 g; wt: 41.3±32.3 ml/min/100 g, 20 s post-release). In 283 
wt mice, this first perfusion peak was followed by a drop to reach a plateau around a value of 284 
26.6±9.2 ml/min/100 g peaking at 270 s post-ischemia. In contrast, mdx muscle perfusion 285 
slightly increased to a mean perfusion value of 84.8±24.8 ml/min/100 g at 300 s post-286 
ischemia and reduced to 26.3±25.9 ml/min/100 g only 850 s after stress release (Figure 5A). 287 
Moreover, the global volume repaid after ischemia was significantly higher in mdx mice (wt: 288 
474.3±216.3 ml/100 g; mdx: 1017.0±369.2 ml/100 g, p<0.05). The response to ischemic 289 
stress was therefore different and enhanced in young-adult mdx mice while almost no 290 
morphological modification of microvessels was detected.  291 
 292 
Muscle bioenergetics in young-adult mice (Table 2). 293 
At rest, mdx mice displayed a slightly higher Pi/PCr ratio compared to wt which reflects an 294 
increase in ADP concentration in dystrophic mice. In addition, a lower PCr/$ATP ratio was 295 
observed in mdx mice, reflecting a decrease in metabolically functional muscle tissue.  296 
The 30 min ischemic stress induced a higher Pi/PCr ratio in mdx mice while PCr depletion 297 
tended to be accelerated compared to wt (mdx: &PCr = 65±9%; wt: &PCr = 58±6%; p=0.09). 298 
At reactive hyperaemia, release revealed a significant acceleration of PCr resynthesis rate in 299 
mdx mice compared to wt, reflecting higher mitochondrial ATP production in the mdx. 300 
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However, contrarily to wt, combined 31P-NMRS and perfusion results showed a very tight 301 
correlation between time of rephosphorylation 'PCr and various parameters reflecting 302 
perfusion: maximum perfusion (r2= 0.66, p<0.05), time-perfusion integrals (r2= 0.99, p<0.001 303 
until 30 sec; r2>0.93, p<0.01 until 150s) (Figure 6). In wt, none of the correlations between 304 
'PCr and perfusion were significant. 305 
In summary, phosphate metabolism was accelerated during ischemia in 3 month-old mdx 306 
mice. At recovery, mitochondrial oxidative rephosphorylation was unexpectedly faster and 307 
perfusion was increased in comparison to age-matched control mice. Moreover, perfusion in 308 
mdx was directly related to mitochondrial ATP production. This is unlike normal healthy 309 
case where a luxury perfusion is observed and is neither limiting nor correlated to 'PCr. 310 
 311 
Alteration of microvascular network organisation in old Flk1GFP/+::mdx mouse.  312 
Old mdx mice displayed marked histological lesions; some already observed in young-adult 313 
as anisocytosis or centrally nucleated myofibers, others included persistence of chronic 314 
inflammation, and presence of endomysial/perimysial fibrosis (Figure 7A-D). The 315 
microvascular network was as well organised in old Flk1GFP/+ as in young-adult mice (Figure 316 
7E). In contrast, Flk1GFP/+::mdx mice displayed significant alterations, characterised by a 317 
marked increase in tortuosity and irregular scattering of microvessels (Figure 7F). 318 
Microvessel diameter was similar in both groups (12 µm), but we identified a higher 319 
anastomose count, from more than 50,000 anastomoses/mm3 for Flk1GFP/+::mdx mice to less 320 
than 1,000 anastomoses/mm3 for control Flk1GFP/+ (p<0.01) (Figure 7J). Collectively, these 321 
results pointed to an anarchic blood vessel organisation in this context of dystrophinopathy. 322 
Immunofluorescence analyses showed that (i) myofiber cross-section mean diameter was 323 
smaller in mdx mice (mdx: 47.4±4.2 µm; wt: 61.2±3.9 µm; p<0.001) (Figure 8C), (ii) the 324 
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smaller myofibers (<50µm) were clearly under-vascularised (Figure 8E), (iii) perinucleated 325 
(Figure 8G), and (iv) represented almost 60% of total muscle fibers in mdx mice in contrast 326 
to 35% in controls (Figure 8D). Alterations were also detected at the terminal arteriole level, 327 
as a loss of 70% of !SMA expression was detected in old mdx mice (wt: 88.6±2.4%, n=7; 328 
mdx: 18.0±2.1%, n=8; p<0.001), suggesting a marked decrease in terminal arteriole density 329 
(Figure 3M, N, P). These data suggested either a progressive degradation of tissue with no 330 
maintenance of microvascular network with time or a defect of neo-angiogenesis. The CFPE 331 
was not affected in old mice (Figure 8F). 332 
Angiogenesis-related mRNA expression analysis revealed a collapse of VEGF expression 333 
and its decoy receptor Flt1 (Figure 4B). As observed in young-adult mice, nNOS was also 334 
significantly decreased in old mdx mice. 335 
Collectively, these results pointed out severe alterations of microvessel organisation, 336 
especially around small/atrophic myofibers, associated with alteration of angiogenesis, 337 
suggesting chronic alteration of endothelial-myogenic cell interface. 338 
 339 
Pericytes and satellite cells in old mdx mice. 340 
The density of pericytes was similar between wt and mdx mice but, in contrast to young-adult 341 
mdx mice, a decrease in satellite cell count was observed for old mdx mice (wt: 12.4±0.6 342 
SC/mm2, n=8; mdx: 10.0±0.8 SC/mm2, n=9; p<0.05) (Figure 3E-H). 343 
 344 
Alteration of muscle perfusion in old mdx mice.  345 
Despite severe alterations in mdx muscle microvascular network organisation, at rest, no 346 
difference in muscle perfusion was observed between mdx and wt mice (mdx: 12.09±5.90 347 
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ml/min/100 g; wt: 8.19±2.19 ml/min/100 g). After tourniquet release, rapid increase of 348 
perfusion was detected in muscles of the posterior hindlimb compartment; this increase was 349 
significantly lower in old mdx mice (mdx perfusion maximal value at 380 s post-ischemia: 350 
60.5±39.3 ml/min/100 g; wt perfusion maximal value at 400 s post-ischemia: 106.1±38.1 351 
ml/min/100 g, p<0.05), in contrast to what was seen in young-adult mice. 352 
Analysis of variance of perfusion time-courses demonstrated differing profiles between wt 353 
and mdx mice (p<10-4), with specific differences in the early phase of reperfusion. A similar 354 
initial peak of perfusion, as the one observed in young-adult wt mice, was detected in the old 355 
wt group, 20 s post-ischemia, but was absent in mdx mice (Figure 5B). 356 
Thus at 12 months, both mdx and wt showed different profiles from young-adult animals 357 
(ANOVA, p<10-6), and in contrast to wt and young-adult mdx, old mdx mice displayed a 358 
decrease in muscle perfusion and a modified perfusion profile after an ischemic stress. 359 
 360 
Muscle bioenergetics in 12 month-old mice (Table 3). 361 
At rest, no difference in pH was observed between wt (n=7) and mdx (n=5) mice but hypoxic 362 
stress induced a significant acidosis in both groups (p<0.005), more pronounced in mdx (wt: 363 
&pH = 0.22±0.06; mdx: &pH = 0.30±0.04; p<0.05). Ischemia was associated with a 364 
significant increase in PCr depletion in old dystrophic mice compared to wt, though the 365 
difference in Pi/PCr ratio between the two groups was not significant. Unlike in young-adult 366 
mice, the rephosphorylation rate was comparable in both groups. Indeed 'PCr was shorter in 367 
the old compared to the young-adult wt mice (p<0.01), but was unchanged with age in the 368 
mdx mice. Thus no alteration of oxidative capacities was observed in old mdx mice in 369 
response to hypoxic stress compared to age-matched control mice, despite reduced perfusion. 370 
In older mice (wt and mdx), no correlation was found between 'PCr and perfusion variables. 371 
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 372 
DISCUSSION 373 
Our study deciphers lesions of muscle microvascular network, in a model of 374 
dystrophinopathy, using combination of state of the art histology/morphometry techniques 375 
and totally non-invasive functional approach. This experimental paradigm, combining 376 
histopathology and mpf-NMR, clearly relevant for clinical diagnosis and research, allowed us 377 
to associate for the first time the fine 3D-alterations of muscle microvascular network with 378 
functional repercussions on muscle. 379 
Concerning the animal model, previous studies used 6 week to 6 month-old mdx mice 12, 14, 25, 380 
which display very few chronic lesions with no fibrosis, in contrast to what happens in 381 
human 16. We therefore worked on 12 month-old mdx mice, displaying persistence of 382 
endomysial inflammation and fibrosis, more representative of human DMD and thus more 383 
relevant for chronic myopathy and DMD pathophysiology study, in contrast to young-adult 384 
mdx mice displaying no chronic lesions. We demonstrated (i) strong alterations of 385 
microvascular network structure associated with reduced muscle perfusion in old mdx mice, 386 
(ii) functional increase in muscle perfusion and mitochondrial oxidative phosphorylation with 387 
normal microvascular network organisation in young-adult mdx mice, and (iii) a different 388 
impact of age on wild-type and mdx mouse muscles. 389 
In young-adult and old wild-type mice, no alteration could be detected in muscle histology or 390 
microvascular network organisation. Perfusion is primarily regulated by smooth muscles that 391 
control blood flow distribution and capillary recruitment 26. Capillary resistance, at rest, plays 392 
only a minor role in perfusion regulation. Using ischemia-reperfusion, we provoke maximal 393 
arteriolar dilatation in order to limit arteriolar resistance, and thus microvessel network 394 
becomes predominant in control of muscle perfusion 27. Analysis of perfusion profiles 395 
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revealed the existence of a “peak” of perfusion in the first seconds after ischemia release, for 396 
young-adult and old wild-type mice. This initial “peak” suggests specific regulation of 397 
perfusion in early phase after ischemia release, probably coordinated by perivascular smooth 398 
muscles and/or pericytes 28. 399 
Surprisingly and in contrast to previous studies describing decreased vascular density 12, 14, we 400 
did not detect any alteration in vascular network 3D-organisation in young-adult mdx mice. 401 
However, muscle post-ischemic perfusion was higher than in aged-match control mice, and 402 
time resolution of mpf-NMR allowed to demonstrate the absence of the initial “peak” of 403 
perfusion. In the same time, we also demonstrated a 26% loss of #SMA expression in young-404 
adult mdx muscle (and more than 70% loss in old mdx), suggesting a drop in perivascular 405 
smooth muscle cells, responsible for part of these deleterious effects. It has indeed been 406 
demonstrated in vivo that the re-expression of dystrophin only in smooth muscle cells 407 
significantly ameliorates vasoregulation in mdx mice 29 confirming the importance of 408 
perivascular cells (smooth muscle for example) in blood flow regulation. One of the possible 409 
key factor is NO production alteration 30 or impairment of neuronal NO synthase (nNOS) 30-32, 410 
very probably explaining the significant decrease in nNOS expression both in young-adult 411 
and old mdx mice, in our study. Concerning pericytes, Yemisci et al. demonstrated in the 412 
brain, after a 2h ischemic stress, that pericytes remain contracted despite successful re-413 
opening of blood flow, impairing microcirculatory reflow 28. These experiments were carried 414 
out ex vivo, and no functional in vivo validation was done. Our data seem therefore to 415 
highlight functional alterations of smooth muscles and/or pericytes after ischemic stress. This 416 
alteration is severe enough to significantly impact perfusion profiles between control and 417 
mdx mice, and we are currently carrying out new experiments to better understand the effect 418 
of an absence of dystrophin in perivascular cells and their involvement in dystrophinopathy 419 
pathophysiology. 420 
 20 
Old Flk1GFP/+::mdx model allowed us to highlight disorganisation of microvascular network. 421 
A marked increase in microvessel tortuosity, an irregular scattering, and an increase in 422 
anastomose count were observed. Existence of these highly abundant anastomoses, suggests 423 
that “radial” as well as “longitudinal” (parallel to myofibers) blood flow is important, and in 424 
turn, that “longitudinal” flow is abnormally heterogeneous, microvessel longitudinal 425 
resistance being likely to vary a lot from microvessel to microvessel which would be the 426 
driven force for collateral flow. 427 
Considering the close association between microvessels and myofibers, we demonstrated in 428 
old mdx mice that more than 60% of myofibres were atrophic with peripheral nuclei and 429 
displayed less microvessels at their periphery, resulting in a global undercapillarisation and 430 
loss of terminal arterioles. In parallel, NMR analysis revealed a two-fold decrease in 431 
perfusion after ischemia release. The significant decrease of microvessel (capillary and 432 
terminal arteriole) density around small myofibers is likely responsible for these functional 433 
alterations. Our data are thus in agreement with other studies demonstrating the effect of age 434 
on dystrophinopathy pathophysiology 15, 25. Our hypothesis is that interaction between 435 
angiogenesis and myogenesis could be affected in old mdx mice; the increasingly scarce 436 
microvessels would provoke an alteration of myofiber regeneration that in turn could lead to 437 
impairment of remaining microvascular network support, maintaining a vicious circle. With 438 
this idea, we focused on the dynamic of satellite cell density in the muscle tissue. While SC 439 
density in young-adult mdx mice was increased, very probably because of the stimulation of 440 
muscle regeneration, it collapsed in old mdx mice, with pathology evolution, suggesting a 441 
worsening of the situation and an increase in the severity of chronic muscle lesions. Decline 442 
in SC number and activity has already been observed with age in mdx mice, in association 443 
with attenuated Notch signalling transduction 33. Christov et al. already introduced the idea 444 
that angiogenesis and myogenesis are coupled during muscle regeneration, these processes 445 
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involving several growth factors, such as VEGF 24. In our study, we also observed 446 
modifications of VEGF and its receptor Flt1 expression profiles. Flt1 is the decoy receptor of 447 
VEGF 34, acting as a negative regulator of endothelial cell growth and differentiation. A 448 
previous study demonstrated that mdx mice knock out for the Flt1 receptor (mdx:Flt1+/-) 449 
presented an improved muscle histology associated with a better muscle perfusion and force 450 
production compared to mdx mice 35. These data underlines the link between vascular 451 
remodelling and muscle regeneration, even in severe chronic diseases. Concerning VEGF, the 452 
2-fold decreased expression, detected in old mdx mice, was in accordance with previous 453 
studies demonstrating that treatment with VEGF strongly ameliorates mdx phenotype, with 454 
improvement of functional parameters, increase in capillary density, improved muscle 455 
regeneration, and decrease in interstitial fibrosis 36, 37. Fibrosis is incidentally a key parameter 456 
influencing perfusion, and is increased in DMD 10. However, fibrosis might not be the most 457 
limiting factor to perfusion, as it only represents 10% of old mdx mice muscle tissue in our 458 
study. Moreover, distance between capillaries and myofibers, generally modified with 459 
endomysial fibrosis 22, is similar between young-adult and old wild-type and mdx mice.  460 
The in vivo increase of post-ischemic muscle perfusion with old age in wt animals was found 461 
to be reproducible in different mouse strains, but no explanation is currently put forward, 462 
while effect of aging on perfusion is still debated even in humans 38, 39.  463 
In parallel to perfusion analysis, acquisition of 31P-spectroscopy revealed moderate energetic 464 
metabolism alterations, in agreement with previous literature, and contrarily to what might be 465 
expected from alterations of enzymatic activities or defects of mitochondrial localization in 466 
vitro. Compensatory mechanisms must thus exist in dystrophic muscle 40-42. 467 
As for perfusion, anomalies in phosphorus metabolites in wild-type animals depended on age, 468 
as already evoked in early studies of mdx metabolism 41, 43. Anomalies at rest were more 469 
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marked in younger mdx: Pi/PCr reflecting resting ADP production was increased while 470 
PCr/ATP proportional to functional muscle was reduced (-11%), coherently with other 471 
reports 40-42 (-50% or more in DMD children 44). 472 
Unlike a recent study in 3 month-old mdx mice 45, where 10min ischemia was used as stress 473 
protocol, we found greater depletion after 30min ischemia in both young-adult and old mdx. 474 
During prolonged ischemia, two energetic pathways are activated to supply ATP demand: 475 
ATP-PCr system and glycolytic pathway. Production of ATP directly from PCr consumption 476 
is very small; it is therefore unlikely that PCr would be consumed to compensate for 477 
defective glycolytic pathway. The higher depletion observed in both young-adult and old 478 
mdx could more likely reflect a higher ATP demand to maintain ionic homeostasis. 479 
Confrontation between perfusion and metabolic data obtained simultaneously by NMR 480 
revealed that despite strongly reduced perfusion in old mdx mice, oxidative metabolism was 481 
preserved, suggesting existence of a “luxury perfusion”, i.e. reserve of perfusion that can be 482 
eliminated without impact on muscle physiology, as previously evidenced in a model of 483 
peripheral artery disease 46. It generally explains the absence, or very loose correlation, 484 
between perfusion and PCr recovery rates in wt animals and in old mdx. This contrasts with 485 
the tight correlation between initial perfusion and 'PCr of young-adult mdx mice, which 486 
display faster 'PCr recovery and stronger perfusion than controls. Using optical spectroscopy 487 
to analyse myoglobin and haemoglobin oxygen desaturation in parallel to 31P-NMRS, 488 
Percival observed strong uncoupling between ATP synthesis and O2 consumption in 4 month-489 
old mdx, dystrophic muscle producing 39% ATP less per O2 consumed than controls 45. We 490 
might thus hypothesize that at this young age, increased perfusion might be a means to 491 
compensate for mitochondrial inefficiency. 492 
 493 
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In conclusion, we demonstrated strong structural and functional alterations in muscle 494 
microvascular network of dystrophin-deficient mdx mice, with an increasing severity in 495 
parallel to aging. Our approach combining 3D-morphological analyses with non-invasive 496 
functional evaluation, allowed to better characterise the impact of histological lesions on 497 
tissue function. Collectively, our data pointed out that vascular network has a key role in 498 
dystrophinopathy pathophysiology and would be very important target for the set-up of new 499 
innovative therapeutic strategies. 500 
 501 
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FIGURE LEGENDS 658 
FIGURE 1. Normal microvascular network organisation in 3 month-old mdx mice. 659 
In contrast to wild-type mice (A), mdx mice (B) display subacute lesions in Gastrocnemius 660 
muscle, characterised by small inflammatory infiltrates (star) associated with regenerated 661 
myofibers displaying central nuclei (arrows) (HE staining). 662 
Microvessel 3D organisation of Flk1GFP/+ (C,E) and Flk1GFP/+::mdx (D,F) mice: normal blood 663 
microvessel organisation, with microvessels regularly scattered along myofibers (C-F) (Scale 664 
bars: 50 µm). Morphometric analyses revealed similar diameter (G) and anastomose 665 
count/mm3 (H) between microvessels from wild-type and mdx mice.  666 
 667 
FIGURE 2. Microvessel morphometry in 3 month-old mice. 668 
Young-adult wild-type (n=5) and mdx (n=3) mice display similar: microvessel distribution in 669 
Gastrocnemius muscle (A,B) (laminin-FITC and CD31-TRITC immunohistochemistry to 670 
label basal lamina (green) and blood vessels (red); Scale bar: 50 µm), fiber size repartition 671 
(C), microvessel count per fiber (D), microvessel diameter (E), and capillary to fiber 672 
perimeter exchange index (CFPE) (F). 673 
 674 
FIGURE 3. Satellite cells, terminal arterioles and pericytes are affected in mdx mice. 675 
Pool of SC was analysed by immunohistochemistry (A, B, E, F, white arrows) (Pax7-FITC 676 
and Laminin-Cy3). SC density is increased in young-adult mdx mice (C, D) while we 677 
observed a significant depletion of the SC pool in old mdx mice (G, H). Pericyte density, 678 
assessed using NG2 immunolabeling (NG2-FITC), was similar for all groups, at all ages (I-679 
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K, M-O). We also evaluated the expression of #SMA (Smooth Muscle Actin) by perivascular 680 
smooth muscle cells, surrounding terminal arterioles (#SMA-Cy3). We observed a decrease 681 
of 26% #SMA expression for young-adult mdx mice in comparison to wt animals (I, J, L), 682 
reaching 70% loss for old mdx (M, N, P), suggesting a marked drop in terminal arterioles, 683 
increasing with the disease progression (scale bars: 25 µm) (*p<0.05, **p<0.01, 684 
***p<0.001). 685 
 686 
FIGURE 4. Analysis of angiogenesis-related gene expression by RT-qPCR. 687 
Total RNA was extracted and complementary DNA was analysed by qPCR. Gene expression 688 
was measured in the Gastrocnemius of young-adult (A) and old (B) mdx mice. Results were 689 
normalized relative to the expression of the 18s rRNA housekeeping gene. Data are presented 690 
as fold change mean±SEM. Symbol ** indicates statistical difference (p<0.01) observed 691 
between mdx and wild-type mice from the same age. 692 
 693 
FIGURE 5. Muscle blood perfusion during ischemia-reperfusion. 694 
After release of ischemia, a rapid and important increase in perfusion is detected. 695 
(A) Different profiles of perfusion are obtained in young-adult mice: total perfusion is higher 696 
in mdx mice and a first “peak” of perfusion followed by a rapid decrease in muscle perfusion 697 
is only detected in wild-type mice.  698 
(B) A first “peak”, similar to what is observed in young-adult wild-type mice, is also 699 
observed in 12 month-old control animals. This first “peak” does not exist in mdx mice that 700 
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also displayed a reduced perfusion, with a maximum perfusion equivalent to half the value 701 
observed in wild-type mice during the hyperaemia phase. 702 
As the release of ischemia induced movements of the leg, images affected by these 703 
movement artefacts are removed from analysis of muscle perfusion.  704 
 705 
FIGURE 6. Correlation between perfusion and time of creatine rephosphorylation ($PCr) in 706 
3 month-old mice. 707 
Correlation between $PCr and maximal perfusion (A) or time-perfusion integrals until 30 sec 708 
(B) is significant in mdx mice (*p<0.05 and ***p<0.001, respectively) with a coefficient of 709 
determination r2 of 0.66 and 0.99, respectively. In wt, none of the correlations were 710 
significant. 711 
 712 
FIGURE 7. Alteration of microvascular network in 12 month-old mdx mice. 713 
Twelve month-old wild-type mice display histologically normal muscles (A), with no fibrosis 714 
(C), and regularly scattered microvessels along myofibers, with few anastomoses (E,G,J). In 715 
contrast, 12 month-old mdx mice display chronic histological lesions (B), characterised by 716 
multifocal inflammatory infiltrates (mostly macrophages), included in endomysial collagen 717 
tissue (fibrosis; stars), associated with a marked variation in myofiber size (anisocytosis) and 718 
the presence of atrophic and regenerating myofibers displaying centrally-located nuclei 719 
(arrows). Sirius red staining and fluorescence microscopy reveal a moderate to marked 720 
endomysial fibrosis (D) and microvascular network alterations (F,H), characterised by 721 
irregularly scattered tortuous microvessels (Scale bars: 50 µm). Even if microvessel diameter 722 
is similar between mdx and wild-type mice (I), a clear increase in anastomose count/mm3 is 723 
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detected for old mdx mice (J). A, B: HE staining. C, D: Sirius red staining (specific for 724 
collagen staining). **p<0.01. 725 
 726 
FIGURE 8. Twelve month-old mdx mice display atrophic myofibers with low capillarisation 727 
and terminal arteriole density. 728 
Anisocytosis is more pronounced in old mdx mice, with the presence of small atrophic 729 
myofibers (A-C) (Laminin-FITC and CD31-TRITC immunohistochemistry; Scale bars: 50 730 
µm). Atrophic myofibers (with a diameter up to 60 µm) represent more than 60% of the total 731 
myofibers in mdx mice (D). These atrophic myofibers display less microvessels at their 732 
periphery (E). The distance between microvessels and myofibers, calculated using the 733 
capillary to fiber perimeter exchange index (CFPE) is similar in both groups (F). Small 734 
myofibers with low capillarisation are mostly perinucleated myofibers (G) (**p<0.01, 735 
***p<0.001). 736 
 737 
  738 
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TABLES 739 
Table 1. Oligonucleotide Primers Used for qPCR 740 
Primer  Sequence 
18S rRNA F 5'-CGGACAGGATTGACAGATTG-3' 
18S rRNA R 5'-CAAATCGCTCCACCAACTAA-3' 
Flk1 F 5'-CAGTGGTACTGGCAGCTAGAAG-3' 
Flk1 R 5'-ACAAGCATACGGGCTTGTTT-3' 
Flt1 F 5'-GGCCCGGGATATTTATAAGAAC-3' 
Flt1 R 5'-CCATCCATTTTAGGGGAAGTC-3' 
VEGF F 5'-GGCGTGGTGGTGACATGGTT-3' 
VEGF R 5'-ACCTCACCAAAGCCAGCACA-3' 
CD31 F 5'-CGGTGTTCAGCGAGATCC-3' 
CD31 R 5'-ACTCGACAGGATGGAAATCAC-3' 
Ang1 F 5'-GACAGTAATACAACACCGGGAAGA-3' 
Ang1 R 5'-CAAAACCCATTTTATACTCCTTCCA-3' 
Ang2 F 5'-ACTACGACGACTCAGTGCAAAG-3' 
Ang2 R 5'-TCTGGTTCTGCACCACATTC-3' 
Tie1 F 5'-AGGGCAGCTTCCAGAGTATG-3' 
 36 
Tie1 R 5'-GGTTGGCCAGCAATGTTAAG-3' 
Tie2 F 5'-GGCTATAAGGATACGGACCATGAA-3' 
Tie2 R 5'-TCCCCTGTCCACGGTCATA-3' 
nNOS F 5'-GGCGTTCGTGATTACTGTGA-3' 
nNOS R 5'-TCTTCCTCATGTCCAAATCCA-3' 
 741 
  742 
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Table 2. Energetic metabolism analysis from 31P-spectroscopy in young-adult mice. 743 
  wt (n=9) mdx (n=6) 
%PCr (%) 58 ± 6 65 ± 9 
$PCr (s) 118 ± 34 76 ± 34* 
   pH at rest (pHrest) 7.20 ± 0.04 7.17 ± 0.03 
pH end ischemia (pHend) 7.00 ± 0.08 6.98 ± 0.03 
   Pi/PCr at rest (Pi/PCrrest) 0.08 ± 0.03 0.10 ± 0.01* 
Pi/PCr end ischemia (Pi/PCrend) 0.93 ± 0.25 1.71 ± 0.52* 
PCr/ATP$ at rest (PCr/ATP$rest) 3.39 ± 0.25 3.01 ± 0.27* 
PCr/ATP$ end ischemia (PCr/ATP$end) 1.80 ± 0.62 1.39 ± 0.51 
 744 
Ischemia stress was sufficient as the mean depletion of phosphocreatine (PCr) for wt and 745 
mdx mice was above 50%. Pi/PCr at rest and after ischemia were higher in mdx compared to 746 
wt mice while PCr/ATP& at rest was lower (*p<0.05). 747 
  748 
 38 
Table 3. Energetic metabolism analysis from 31P-spectroscopy in old mice. 749 
  wt (n=7) mdx (n=5) 
%PCr (%) 54 ± 4 63 ± 2** 
$ PCr (s) 66 ± 25 80 ± 20 
   pH at rest (pHrest) 7.16 ± 0.07 7.18 ± 0.04 
pH end ischemia (pHend) 6.94 ± 0.04 6.87 ± 0.04* 
   Pi/PCr at rest (Pi/PCrrest) 0.08 ± 0.04 0.10 ± 0.01 
Pi/PCr end ischemia (Pi/PCrend) 1.24 ± 0.40 1.34 ± 0.20 
PCr/ATP$ at rest (PCr/ATP$rest) 2.98 ± 0.35 3.05 ± 0.16 
PCr/ATP$ end ischemia (PCr/ATP$end) 1.20 ± 0.35 1.36 ± 0.30 
 750 
Ischemia stress was sufficient as the mean depletion of phosphocreatine (PCr) for wt and 751 
mdx mice was above 50%. %PCr is higher in mdx mice; pH decreased for both wt and mdx 752 
mice after ischemia, but mdx mice suffered a more severe acidosis. Others energetic 753 
parameters did not change in our experimental conditions (*p<0.05, **p<0.01). 754 
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